Next Article in Journal
In Vitro Anti-diabetic Activities and Chemical Analysis of Polypeptide-k and Oil Isolated from Seeds of Momordica charantia (Bitter Gourd)
Previous Article in Journal
Design and Synthesis of a Novel Ganglioside Ligand for Influenza A Viruses
Molecules 2012, 17(8), 9621-9630; doi:10.3390/molecules17089621
Article

Populene D Analogues: Design, Concise Synthesis and Antiproliferative Activity

1
,
2
,
2
,
2,*  and , Jr. 1,*
Received: 15 June 2012 / Revised: 2 August 2012 / Accepted: 3 August 2012 / Published: 10 August 2012
(This article belongs to the Section Organic Synthesis)
View Full-Text   |   Download PDF [191 KB, 18 June 2014; original version 18 June 2014]   |   Browse Figures

Abstract

An efficient and concise synthesis of nine populene D analogues was performed using an iodine-catalyzed Prins cyclization as the key transformation. The antiproliferative activity of these new pyrans against several cancer cell lines was then investigated. Among them, an isochromene with moderate activity (mean logGI50 = 0.91) was found. Additionally, compounds with selectivity toward the tumor cell lines NCI-ADR/RES, OVCAR-3, and HT29 were discovered.
Keywords: osochromene; pyrans; Prins cyclization; iodine; antiproliferative; cancer osochromene; pyrans; Prins cyclization; iodine; antiproliferative; cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplement

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Reddy, K.R.K.K.; Longato, G.B.; Carvalho, J.E.; Ruiz, A.L.T.G.; Silva, L.F., , Jr. Populene D Analogues: Design, Concise Synthesis and Antiproliferative Activity. Molecules 2012, 17, 9621-9630.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert